Back

The negative symptoms of schizophrenia: lessons from a precision nomothetic psychiatry approach

Maes, M.

2022-05-27 psychiatry and clinical psychology
10.1101/2022.05.26.22275663
Show abstract

The present study aims to explain how to use the precision nomothetic approach to analyze the interconnections between the negative symptoms, cognitive dysfunctions and biomarkers of schizophrenia. We review our data obtained in different study groups of patients with (deficit) schizophrenia and show, using examples extracted from these studies, how Partial Least Squares (PLS) path analysis should be used to examine these complex associations. PLS path analysis combines factor and multiple regression analysis in mediated models. We show that a single latent trait can be extracted from negative symptom domains and psychosis, hostility, excitation, mannerism, formal thought disorders and psychomotor retardation (PHEMFP). Both the negative and PHEMFP concepts miss discriminant validity whilst a common latent construct may be extracted from the 6 negative and 6 PHEMFP subdomains, dubbed overall severity of schizophrenia (OSOS). A common latent factor may be extracted from neurocognitive test scores including executive functions, and semantic and episodic memory dubbed the general cognitive decline (G-CoDe) index. PLS analysis shows that the effects of neuroimmunotoxic pathways on OSOS are partly mediated by the G-CoDe and indicate that those pathways have also direct effects on OSOS. We explain that the intercorrelations between those features should be assessed in an unrestricted study group combining patients and controls. Moreover, further bifactorial factor analysis with the restricted schizophrenia group may disclose illness-specific covariations among the features. Machine learning discovered a new schizophrenia phenotype characterized by increased severity of AOPs, G-CoDe, and OSOS, dubbed "major neurocognitive psychosis".

Matching journals

1
Schizophrenia Bulletin
Oxford University Press (OUP) · based on 21 published papers
Top 0.1%
124× avg
2
Schizophrenia Research
Elsevier BV · based on 11 published papers
#1
247× avg
3
Schizophrenia
Springer Science and Business Media LLC · based on 13 published papers
#1
188× avg
4
NeuroImage: Clinical
Elsevier BV · based on 77 published papers
Top 2%
14× avg
5
Biological Psychiatry
Elsevier BV · based on 36 published papers
Top 1%
24× avg
6
Translational Psychiatry
Springer Science and Business Media LLC · based on 94 published papers
Top 3%
9.4× avg
7
Scientific Reports
Springer Science and Business Media LLC · based on 701 published papers
Top 38%
4.8%
8
PLOS ONE
Public Library of Science (PLoS) · based on 1737 published papers
Top 71%
4.6%
9
Human Brain Mapping
Wiley · based on 53 published papers
Top 3%
7.8× avg
10
Psychological Medicine
Cambridge University Press (CUP) · based on 52 published papers
Top 4%
7.3× avg
11
Molecular Psychiatry
Springer Science and Business Media LLC · based on 84 published papers
Top 5%
5.0× avg
12
Cerebral Cortex
Oxford University Press (OUP) · based on 15 published papers
Top 0.8%
27× avg
13
European Journal of Neuroscience
Wiley · based on 10 published papers
Top 0.4%
34× avg
14
Frontiers in Psychiatry
Frontiers Media SA · based on 56 published papers
Top 6%
3.7× avg
15
Progress in Neuro-Psychopharmacology and Biological Psychiatry
Elsevier BV · based on 10 published papers
Top 0.7%
16× avg
16
Psychiatry Research
Elsevier BV · based on 33 published papers
Top 5%
4.3× avg
17
Neuroscience & Biobehavioral Reviews
Elsevier BV · based on 19 published papers
Top 3%
7.0× avg
18
Brain, Behavior, and Immunity
Elsevier BV · based on 35 published papers
Top 3%
5.2× avg
19
Journal of Psychiatric Research
Elsevier BV · based on 22 published papers
Top 3%
8.5× avg
20
Frontiers in Public Health
Frontiers Media SA · based on 135 published papers
Top 28%
0.7%
21
Journal of Affective Disorders
Elsevier BV · based on 72 published papers
Top 6%
1.7× avg
22
International Journal of Environmental Research and Public Health
MDPI AG · based on 116 published papers
Top 24%
0.7%